Patent · US Active

Sustained-release nucleic acid matrix compositions

US9616032B2 · kind B2 · utility

2Cited by
26References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2014
Grant dateApr 11, 2017
Priority date
Expiry dateDec 16, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are provided compositions for extended release of a nucleic acid agent, comprising a lipid-saturated matrix formed with a biodegradable polymer. Also provided are methods of producing the matrix compositions and methods for using the matrix compositions to provide controlled release of the nucleic acid agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.